BCAL Director Adds Shares Through On-Market Purchase
BDX: $0.064 +0.00% · MC: $22M
BCAL Diagnostics director Jayne Shaw acquired 72,315 shares on market, increasing the holding in her family account while her other disclosed holdings remained unchanged. The purchase was made on 5 November.

Comments